Large-Scale Immunomagnetic Selection of CD14+Monocytes to Generate Dendritic Cells for Cancer Immunotherapy: A Phase I Study (Q51803810)

12 April 2018

reason for preferred rank

title

Large-Scale Immunomagnetic Selection of CD14+Monocytes to Generate Dendritic Cells for Cancer Immunotherapy: A Phase I Study (English)

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

27 March 2024

Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14594508

27 March 2024

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

27 March 2024

Ehninger G

1 reference

12 April 2018

Martin Bornhäuser

object named as

Bornhäuser M

1 reference

12 April 2018

author name string

J. Babatz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14594508

27 March 2024

C. Röllig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14594508

27 March 2024

U. Oelschlägel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14594508

27 March 2024

S. Zhao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14594508

27 March 2024

M. Schmitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14594508

27 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14594508

27 March 2024

publication date

1 October 2003

1 reference

12 April 2018

full work available at URL

https://www.liebertpub.com/doi/pdf/10.1089/152581603322448222

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1089/152581603322448222

Journal of Hematotherapy and Stem Cell Research

27 March 2024

published in

1 reference

12 April 2018

volume

1 reference

12 April 2018

issue

1 reference

12 April 2018

page(s)

515-523

1 reference

12 April 2018

Immunobiology of dendritic cells

cites work

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Dendritic cells and the control of immunity

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Dendritic cells in cancer immunotherapy

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34+ progenitors

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Hematology and cell therapy

27 March 2024

Bernard J

1998

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1089/152581603322448222

In vitro production of dendritic cells from human blood monocytes for therapeutic use.

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Simplified method to generate large quantities of dendritic cells suitable for clinical applications

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use.

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Generation of large numbers of dendritic cells in a closed system using Cell Factories.

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Dendritic cell-based vaccination in solid cancer.

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back

27 March 2024

1 reference

https://api.crossref.org/works/10.1089/152581603322448222

27 March 2024

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018